Engineering an Affinity-directed Protein Missile System (AdPROM) for inducible degradation of target proteins

设计亲和定向蛋白质导弹系统 (AdPROM) 以诱导降解目标蛋白质

基本信息

  • 批准号:
    2253315
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Studentship
  • 财政年份:
    2019
  • 资助国家:
    英国
  • 起止时间:
    2019 至 无数据
  • 项目状态:
    已结题

项目摘要

Achieving a rapid and efficient degradation of endogenous proteins of interest (POIs) in cells is desirable as a research toolkit to understand protein function, and for therapeutic targeting of proteins. Protein silencing through gene knockouts, for example by CRISPR/Cas9 genome editing, are irreversible, time consuming and often not feasible. Similarly, RNA interference approaches require prolonged treatments, can lead to incomplete protein depletion and are often associated with off-target effects. Direct proteolysis of POIs can potentially overcome these limitations.The Sapkota lab has developed an affinity directed protein missile (AdPROM) system that allows for rapid and efficient destruction of endogenous target proteins in many cell lines (1, 2). The proteolytic AdPROM system fuses small, high-affinity polypeptide binders, such as nanobodies and monobodies, of specific proteins and the von Hippel-Lindau (VHL) protein to recruit the CUL2-RING E3 ligase complex. The resulting AdPROM system, when delivered in any cell, through retroviral infections, leads to efficient degradation of endogenous target proteins through the proteasome. The Ciulli lab works on developing small molecule degraders, also known as proteolysis targeting chimeras (PROTACs), that induce specific proteins in cells to be degraded via the ubiquitin proteasome system (3). The Ciulli lab has developed PROTACs that selectively and rapidly degrade the HALO-tagged proteins from cells by recruiting them to VHL-CUL2 E3 ligase complex for proteasomal destruction of the HALO-tagged proteins. A key requirement for this approach is that the endogenous target proteins need to be tagged with a HALO-tag first in order for the HaloPROTACs to work. Introducing a HALO-tag on an endogenous protein is not only challenging but can often compromise the function of the protein as well.This project aims to develop an effective inducible AdPROM system by fusing nano/monobodies with a HALO-tag and inducibly degrade the proteins of interest targeted by the nano/monobodies using HaloPROTACs. The advantage of this system is that it will be applicable to any cell lines where the target protein is expressed and so the function of the protein can be rapidly assessed in any cellular context. In the absence of an effective targeting nano/monobodies, CRISPR/Cas9 genome editing can be used to rapidly introduce a GFP-tag on the target protein first and use anti-GFP nanobody fused to HALO-tag as the inducible AdPROM for the degradation of the POI. After developing a robust AdPROM technology, its efficacy to degrade a wide array of target proteins in many different cell types will be tested. Novel HaloPROTACs will be synthesized in the Ciulli Lab and tested with the goal to optimize the degradation efficiency of the system. This approach has the potential in rapidly evaluating proteolysis as a druggable approach for many so called 'undruggable' target proteins involved in many human diseases. The student will receive excellent training in multidisciplinary areas: cutting-edge cell biology and biochemistry technologies from the Sapkota lab and state-of-the-art chemical biology techniques from the Ciulli lab. References:1. Fulcher, L. J., Macartney, T. J., Turnbull, C., Hutchinson, L., and Sapkota, G. P. (2017) Targeting endogenous proteins for degradation through the affinity-directed protein missile system. Open biology 7: 1700662. Fulcher, A. J., Macartney, T., Bozatzi, P., Hornberger, A., Rojas-Fernandez, A., and Sapkota, G. P. (2016) An Affinity-directed PROtein Missile (AdPROM) system for targeted proteolysis. Open biology 6:1602551.3. Gadd, M. S., Testa, A., Lucas, X., Chan, K.-H., Chen, W. Lamont, D.J., Zengerle, M. and Ciulli, A. (2017) Structural basis of PROTAC cooperative recognition for selective protein degradation. Nat Chem Biol 13, 514-521.
实现细胞中内源性目的蛋白(POI)的快速有效降解是理解蛋白质功能和蛋白质治疗靶向的研究工具包所需的。通过基因敲除(例如通过CRISPR/Cas9基因组编辑)实现的蛋白质沉默是不可逆的,耗时的,并且通常不可行。同样,RNA干扰方法需要长期治疗,可能导致蛋白质不完全耗尽,并且通常与脱靶效应相关。P0 I的直接蛋白水解可以潜在地克服这些限制。Sapkota实验室已经开发了亲和定向蛋白导弹(AdPROM)系统,其允许快速有效地破坏许多细胞系中的内源性靶蛋白(1,2)。蛋白水解AdPROM系统融合特定蛋白质和von Hippel-Lindau(VHL)蛋白质的小的、高亲和力多肽结合剂,例如纳米抗体和单体抗体,以募集CUL 2-RING E3连接酶复合物。当通过逆转录病毒感染在任何细胞中递送时,所得的AdPROM系统通过蛋白酶体导致内源性靶蛋白的有效降解。Ciulli实验室致力于开发小分子降解剂,也称为蛋白质水解靶向嵌合体(PROTAC),可诱导细胞中的特定蛋白质通过遍在蛋白酶体系统降解(3)。Ciulli实验室已经开发出PROTAC,通过将它们招募到VHL-CUL 2 E3连接酶复合物中,用于HALO标记蛋白的蛋白酶体破坏,选择性地快速降解细胞中的HALO标记蛋白。这种方法的关键要求是内源性靶蛋白需要首先用HALO标签标记,以便HaloPROTAC起作用。在内源性蛋白质上引入HALO标签不仅具有挑战性,而且往往会损害蛋白质的功能。本项目旨在通过将纳米/单抗体与HALO标签融合,并使用HaloPROTAC诱导降解纳米/单抗体靶向的目的蛋白质,从而开发有效的诱导型AdPROM系统。该系统的优点是,它将适用于表达靶蛋白的任何细胞系,因此可以在任何细胞环境中快速评估蛋白质的功能。在缺乏有效靶向纳米/单体抗体的情况下,CRISPR/Cas9基因组编辑可用于首先在靶蛋白上快速引入GFP标签,并使用融合至HALO标签的抗GFP纳米抗体作为用于降解POI的诱导型AdPROM。在开发出强大的AdPROM技术后,将测试其降解许多不同细胞类型中多种靶蛋白的功效。新型HaloPROTAC将在Ciulli实验室合成,并进行测试,以优化系统的降解效率。这种方法有可能在快速评估蛋白水解作为一种药物的方法,许多所谓的'undruggable'的目标蛋白参与许多人类疾病。学生将接受多学科领域的优秀培训:Sapkota实验室的尖端细胞生物学和生物化学技术以及Ciulli实验室的最先进的化学生物学技术。参考文献:1.富尔彻湖J.,Macartney,T. J.,Turnbull,C.,哈钦森湖,和Sapkota,G. P.(2017)通过亲和力导向的蛋白质导弹系统靶向内源性蛋白质降解。开放生物学7:1700662。Fulcher,A. J.,Macartney,T.,Bozatzi,P.,Hornberger,A.,Rojas-Fernandez,A.,和Sapkota,G. P.(2016)一种用于靶向蛋白水解的亲和定向蛋白质导弹(AdPROM)系统。开放生物学6:1602551.3。Gadd,M.美国,泰斯塔,A.,卢卡斯,X,Chan,K.- H、陈威拉蒙,D. J.,Zengerle,M.和Ciulli,A.(2017)选择性蛋白质降解的PROTAC合作识别的结构基础。Nat Chem Biol 13,514-521.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    --
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship

相似海外基金

Microfluidics-enabled directed affinity reagent engineering for fast, sensitive diagnostics
支持微流体的定向亲和试剂工程可实现快速、灵敏的诊断
  • 批准号:
    10527811
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Microfluidics-enabled directed affinity reagent engineering for fast, sensitive diagnostics
支持微流体的定向亲和试剂工程可实现快速、灵敏的诊断
  • 批准号:
    10678870
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Engineering High-Affinity T Cell Receptors Against Cancer Antigens
设计针对癌症抗原的高亲和力 T 细胞受体
  • 批准号:
    9318170
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Engineering High-Affinity T Cell Receptors Against Cancer Antigens
设计针对癌症抗原的高亲和力 T 细胞受体
  • 批准号:
    8704723
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Engineering High-Affinity T Cell Receptors Against Cancer Antigens
设计针对癌症抗原的高亲和力 T 细胞受体
  • 批准号:
    9115467
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Engineering High-Affinity T Cell Receptors Against Cancer Antigens
设计针对癌症抗原的高亲和力 T 细胞受体
  • 批准号:
    8596188
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Engineering high affinity integrin binding proteins
工程化高亲和力整合素结合蛋白
  • 批准号:
    7194212
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
Engineering high affinity integrin binding proteins
工程化高亲和力整合素结合蛋白
  • 批准号:
    7360302
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
Study of the regulation mechanism of ligand affinity of hemoglobin by protein engineering
蛋白质工程研究血红蛋白配体亲和力调控机制
  • 批准号:
    05670043
  • 财政年份:
    1993
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
AFFINITY ENGINEERING OF ANTIPOLYSACCHARIDE MONOCLONAL ANTIBODY
抗多糖单克隆抗体的亲和工程
  • 批准号:
    6161345
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了